[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$kmda](/topic/$kmda)

### Sentiment: %
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$kmda/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$kmda/time-series/sentiment.tsv)  
**Current Value**: %  
**Daily Average**: XX%  
**1 Month**: XX% -XX%  
**1-Year High**: XXX% on 2025-05-20  
**1-Year Low**: XX% on 2025-10-17  

**Most Supportive Themes**
- **Positive Biotech Outlook:** (30%) The biotech sector is trending upwards, creating a positive environment for KMDA.
- **FDA Approval and Research Programs:** (20%) Mentions of FDA approval and post-marketing research programs for CYTOGAM are present.
- **Strong Financials and Potential:** (15%) KMDA is delivering double-digit revenue growth and strong execution, with analysts projecting EPS growth.
  
**Most Critical Themes**
- **Lack of Partner for AATD Trial:** (10%)  The inability to secure a partner for the AATD Phase X trial is a challenge.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %   | Negative | %  |
| ------- | -------- | -  | ------- | -   | -------- | -  |
| X       | X        | X% | XX      | XX% | X        | X% |
|         |          |    |         |     |          |    |
| Total   | X        | X% | XX      | XX% | X        | X% |